CDEK
← All drugs Report issue

ferrous fumarate

Small moleculeapproved

Approved

Feb 21, 1978

Clinical trial activity

25 trials · 39 clinical orgs · 10 marketing orgs

Phase 1
5
Phase 2
7
Phase 3
6
Phase 4
7

Earliest trial started Jan 1, 2000 (NCT02346188)

Timeline

1970s

  1. Feb 21, 1978

    G D Searle — Earliest FDA Approval

  2. Feb 21, 1978

    G D Searle — Marketing Organization

  3. Feb 21, 1978

    G D Searle — NDA Secondary Org

  4. Feb 21, 1978

    G D Searle — NDA Organization

  5. Jul 26, 1979

    Cadence Pharmaceuticals — Marketing Organization

  6. Jul 26, 1979

    Cadence Pharmaceuticals — NDA Secondary Org

1980s

  1. Jul 18, 1986

    Pfizer — NDA Secondary Org

2000s

  1. Jan 1, 2003

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2005

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Oct 21, 2010

    Allergan — NDA Secondary Org

  2. Jan 1, 2014

    Earliest Phase 2 Sponsor(trial)

  3. May 12, 2014

    Lupin — Marketing Organization

  4. Dec 1, 2014

    Barr Laboratories — Marketing Organization

  5. Dec 1, 2014

    Teva — Marketing Organization

  6. Apr 22, 2016

    Glenmark Pharmaceuticals — Marketing Organization

2020s

  1. May 12, 2021

    Amneal Pharmaceuticals — Marketing Organization

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetOTHER

    Supplement

  • IronSupplementation

    Iron supplementation

Combination products

Approval history

  • approvedFeb 21, 1978

Chemistry & pharmacology

Mol. weight
169.9 g/mol
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Delivery
Oral
Availability
Discontinued

Oral

Yes

Parenteral

No

Topical

No

Sources

Also known as

  • feostat
  • feostat
  • feostat
  • ferric fumarate
  • ferric fumarate
  • ferrocap
  • ferrofumerat
  • ferrous fumarate
  • ferrous fumarate
  • ferrous fumarate
  • ferrous fumarate
  • ferrous fumarate
  • ferrous fumarate
  • ferrous fumarate
  • ferrous fumarate
  • fersaday
  • fersaday
  • fersaday
  • fersamal
  • fersamal
  • fersamal
  • ferval
  • fumar
  • galfer
  • galfer
  • galfer
  • hemocyte brand of ferrous fumarate
  • ircon
  • iron fumarate
  • iron fumarate
  • iron fumarate
  • meterfer
  • nephro-fer
  • palafer
  • palaron
  • rulofer n
  • toleron
  • toleron

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06321887Phase 3Oct 20, 2023Royal Liverpool & Broadgreen University Hospitals NHS Truts
NCT05681871Phase 2/Phase 3 (Phase 3)Jan 16, 2023Stellenbosch University, University of Cape Town, University of Kwa-Zulu Natal
NCT03188445Phase 4Jun 30, 2017Pharmacosmos
NCT02437955N/AApr 30, 2015Cheikh Anta Diop University, Senegal, Swiss Federal Institute of Technology, Universite Cheikh Anta Diop
NCT02243735Phase 4Nov 1, 2014University of Amsterdam, Vifor Inc.
NCT02271997Phase 4Oct 1, 2014Rijnstate Hospital
NCT03106454Phase 3Aug 1, 2014Society of Family Planning, University of Southern California
NCT02228902Phase 4Aug 1, 2014Rijnstate Hospital
NCT02128971Phase 2Apr 1, 2014Albion, Sprim Consulting, University of Indonesia
NCT01949467Phase 2Feb 10, 2014University of Rennes
NCT02005588Early Phase 1 (Phase 1)Dec 1, 2013Cairo University
NCT01975272Phase 4Nov 1, 2013Maastricht University, Vifor Inc.
NCT02398968N/AAug 1, 2013Ain Shams University
NCT02831712N/AApr 1, 2013National University of Singapore
NCT01762995Phase 1Dec 1, 2012GlaxoSmithKline, ViiV Healthcare
NCT01656434Phase 3Nov 1, 2012Merck
NCT01155375Phase 3Apr 1, 2011AMAG Pharmaceuticals, Inc.
NCT00999479N/AOct 1, 2009University of Oklahoma
NCT00746551Phase 4Sep 1, 2008Mahidol University, Vifor Inc.
NCT01078818Phase 4May 1, 2007Fundación Canaria Rafael Clavijo para la Investigación Biomédica, University of Las Palmas de Gran Canaria
Showing 20 of 25 trials
Page 1 / 2

Organizations

Research & Development (39)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Vifor Inc.For profit3012008
Rijnstate HospitalAcademic/Hospital2212014
Aalborg UniversityAcademic/Hospital1012006
Ain Shams UniversityAcademic/Hospital1112013
AlbionFor profit1112014
AMAG Pharmaceuticals, Inc.For profit1112011
Boston UniversityAcademic/Hospital1012005
Cairo UniversityAcademic/Hospital1112013
Centers for Disease Control and Prevention (CDC)Government1112005
Cheikh Anta Diop University, SenegalAcademic/Hospital1012015
Fundación Canaria Rafael Clavijo para la Investigación BiomédicaAcademic/Hospital1112007
GlaxoSmithKlineFor profit1012012
Government of DenmarkGovernment1112006
Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranGovernment1012000
International Center for Diarrheal Disease ResearchAcademic/Hospital1112003
Johns Hopkins UniversityAcademic/Hospital1112000
Maastricht UniversityAcademic/Hospital1112013
Mahidol UniversityAcademic/Hospital1112008
MerckFor profit1112012
National Polytechnic Institute, MexicoAcademic/Hospital1012000
39 organizations
Page 1 / 2

Marketing (13)

OrganizationOrg typeRelationshipDate
AllerganFor profitNDA2Oct 21, 2010
Amneal PharmaceuticalsFor profitMKTGMay 12, 2021
Barr LaboratoriesFor profitMKTGDec 1, 2014
Cadence PharmaceuticalsFor profitMKTGJul 26, 1979
Cadence PharmaceuticalsFor profitNDA2Jul 26, 1979
G D SearleFor profitMKTGFeb 21, 1978
G D SearleFor profitNDA2Feb 21, 1978
G D SearleFor profitNDAFeb 21, 1978
Glenmark PharmaceuticalsFor profitMKTGApr 22, 2016
LupinFor profitMKTGMay 12, 2014
Parke-DavisFor profitNDA2—
PfizerFor profitNDA2Jul 18, 1986
TevaFor profitMKTGDec 1, 2014